John E. Janik - Concepedia

Author

John E. Janik

Also Known As

J E Janik, J Janik, J. E. Janik, J. Janik, J.E. Janik, JOHN JANIK, Janik, John, John E Janik, John E. Janik, John Edward Janik

210

Publications

10.5K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research National Institutes of Health Science Applications International Corporation (United States)National Institute of Allergy and Infectious Diseases

About

John E. Janik is an author at National Cancer Institute specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	2.9K
2	Cell Biology	7	7	928
3	Natural Sciences	6	6	381
4	Health Sciences	4	4	619
5	Biochemistry	3	3	112

John E. Janik

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Blood	2010	1.3K
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting Kunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, Journal of Clinical Oncology ImmunologyPathologyImmunotherapyResponse CriteriaHematological Malignancy	2008	546
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman, Blood	2009	498
Brentuximab Vedotin (SGN-35) Jessica Katz, John E. Janik, Anas Younes Clinical Cancer Research ImmunologyPathologyPharmacotherapyImmunotherapyMedicinal Chemistry	2011	358
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology Upendra P. Hegde, Armando Filie, Richard F. Little, Blood	2004	350
Herpes Simplex Virus Types 1 and 2 Completely Help Adenovirus-Associated Virus Replication R. Mark L. Buller, John E. Janik, Edwin D. Sebring, Journal of Virology Aav DnaViral ReplicationMolecular VirologyPathogenesisViral Pathogenesis	1981	325
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy Wyndham H. Wilson, Michael L. Grossbard, Stefania Pittaluga, Blood	2002	325
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance Vivek Verma, Rajeev Shrimali, Shamim Ahmad, Nature Immunology Cancer ImmunosurveillancePd-1 BlockadeSubprimed Cd8 CellsDysfunctional Pd-1+cd38hi CellsImmunology	2019	320
Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga, Journal of Clinical Oncology	2008	303
Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma Stephen J. Schuster, Sattva S. Neelapu, Barry L. Gause, Journal of Clinical Oncology	2011	241

Page 1